Maqual R. Graham Pharm. D. , Colleen Leidwanger Pharm. D.
{"title":"精神病患者变应性鼻炎的预防和缓解症状的治疗策略","authors":"Maqual R. Graham Pharm. D. , Colleen Leidwanger Pharm. D.","doi":"10.1016/S1082-7579(97)00079-4","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Up to 40% of Americans have symptoms of allergic rhinitis, costing the health care system almost 2 billion per year. Allergic rhinitis is an inflammatory disease that results in sneezing, </span>rhinorrhea<span>, and congestion. Allergen avoidance can minimize such symptoms, but pharmacological therapy with antihistamines, </span></span>decongestants<span>, mast cell stabilizers, and corticosteroids may be necessary to effectively treat symptoms. In the psychiatric patient, tobacco use and drug interactions make treatment more complicated. Newly available agents described in this article may prevent treatment complications in the psychiatric patient with allergic rhinitis.</span></p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 1","pages":"Pages 2-6"},"PeriodicalIF":0.0000,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(97)00079-4","citationCount":"0","resultStr":"{\"title\":\"Treatment Strategies for the Prevention and Relief of Symptoms in Psychiatric Patients with Allergic Rhinitis\",\"authors\":\"Maqual R. Graham Pharm. D. , Colleen Leidwanger Pharm. D.\",\"doi\":\"10.1016/S1082-7579(97)00079-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>Up to 40% of Americans have symptoms of allergic rhinitis, costing the health care system almost 2 billion per year. Allergic rhinitis is an inflammatory disease that results in sneezing, </span>rhinorrhea<span>, and congestion. Allergen avoidance can minimize such symptoms, but pharmacological therapy with antihistamines, </span></span>decongestants<span>, mast cell stabilizers, and corticosteroids may be necessary to effectively treat symptoms. In the psychiatric patient, tobacco use and drug interactions make treatment more complicated. Newly available agents described in this article may prevent treatment complications in the psychiatric patient with allergic rhinitis.</span></p></div>\",\"PeriodicalId\":100909,\"journal\":{\"name\":\"Medical Update for Psychiatrists\",\"volume\":\"3 1\",\"pages\":\"Pages 2-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1082-7579(97)00079-4\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Update for Psychiatrists\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1082757997000794\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Update for Psychiatrists","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1082757997000794","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Treatment Strategies for the Prevention and Relief of Symptoms in Psychiatric Patients with Allergic Rhinitis
Up to 40% of Americans have symptoms of allergic rhinitis, costing the health care system almost 2 billion per year. Allergic rhinitis is an inflammatory disease that results in sneezing, rhinorrhea, and congestion. Allergen avoidance can minimize such symptoms, but pharmacological therapy with antihistamines, decongestants, mast cell stabilizers, and corticosteroids may be necessary to effectively treat symptoms. In the psychiatric patient, tobacco use and drug interactions make treatment more complicated. Newly available agents described in this article may prevent treatment complications in the psychiatric patient with allergic rhinitis.